Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MIDr. Molly Imgruet
    Leading Voice

    Dr. Molly Imgruet

    Hematology & Oncology · Leukemia
    Stanford Medicine
    molly
    Stanford, CA

    Research

    Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance

    2025

    Via Blood Neoplasia

    Research

    Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells

    2023

    Via Oncogene

    Research

    Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms

    2021

    Via Blood

    Research

    Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen

    2020

    Via Cytokine

    Research

    Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS

    2018

    Via Blood

    Research

    Combinatorial therapy for triple negative breast cancer using hyperstar polymer-based nanoparticles

    2015

    Via Chem Commun (Camb)